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Modified mesenchymal stromal cells (MSCs) display a unique mechanism of action
during the repair phase of traumatic brain injury by exhibiting the ability to build a
biobridge between the neurogenic niche and the site of injury. Immunohistochemistry
and laser capture assay have visualized this biobridge in the area between the neurogenic
subventricular zone and the injured cortex. This biobridge expresses high levels of
extracellular matrix metalloproteinases (MMPs), which are initially co-localized with a
stream of transplanted MSCs, but later this region contains only few to non-detectable
grafts and becomes overgrown by newly recruited host cells. We have reported that
long-distance migration of host cells from the neurogenic niche to the injured brain
site can be attained via these transplanted stem cell-paved biobridges, which serve as
a key regenerative process for the initiation of endogenous repair mechanisms. Thus,
far the two major schools of discipline in stem cell repair mechanisms support the
idea of “cell replacement” and the bystander effects of “trophic factor secretion.” Our
novel observation of stem cell-paved biobridges as pathways for directed migration of
host cells from neurogenic niche toward the injured brain site adds another mode of
action underlying stem cell therapy. More in-depth investigations on graft-host interaction
will likely aid translational research focused on advancing this stem cell-paved biobridge
from its current place, as an equally potent repair mechanism as cell replacement and
trophic factor secretion, into a new treatment strategy for traumatic brain injury and other
neurological disorders.
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A NOVEL BRAIN REPAIR MECHANISM OF TRANSPLANTED
STEM CELLS
Stem cell research offers an avenue for an in-depth study of
cell biology, as well as in the development of new strategies to
treat diseases (Yasuhara et al., 2006, 2008; Tajiri et al., 2012).
Nevertheless, much remains to be understood about the mech-
anisms underlying the beneficial effects of stem cell therapy. To
date, there are two major schools of discipline in stem cell-
mediated repair mechanism in brain damage caused by injury
or neurodegenerative disorders (Borlongan et al., 2004; Pastori
et al., 2008). The first concept supports the idea of “cell replace-
ment,” i.e., stem cells implanted into the brain directly replace
dead or dying cells (Figure 1A), whereas the other argues that
transplanted stem cells secrete growth factors that indirectly res-
cue the injured tissue (i.e., bystander effects of stem cells) (Lee
et al., 2007; Redmond et al., 2007) (Figure 1B).
Stem cells exist through adulthood (Ma et al., 2010), and pos-
sess the capacity for self-renewal and differentiation into multiple
lineages. They have also been shown to contribute to the mainte-
nance of homeostasis (Kim et al., 2011), exert therapeutic benefits
both endogenously (Barha et al., 2011; Borlongan, 2011; Jaskelioff
et al., 2011; Wang et al., 2011) and following transplantation
into injured organs, e.g., the brain (Mazzocchi-Jones et al., 2009;
Hargus et al., 2010; Lee et al., 2010; Andres et al., 2011; Liu et al.,
2011; Mezey, 2011; Yasuda et al., 2011). There are two major stem
cell niches in the brain namely, the subventricular zone (SVZ)
of the lateral ventricles and the subgranular zone of the hip-
pocampus dentate gyrus (DG) (Carlén et al., 2009; Sanai et al.,
2011), although quiescent neural stem cells (NSCs) have been
found in other brain regions (Robel et al., 2011). The discov-
ery that stem cells are activated following injury opened up new
research frontiers in regenerative medicine (Yasuhara et al., 2006;
Mazzocchi-Jones et al., 2009; Hargus et al., 2010; Lee et al., 2010;
Andres et al., 2011; Barha et al., 2011; Borlongan, 2011; Jaskelioff
et al., 2011; Liu et al., 2011;Mezey, 2011;Wang et al., 2011; Yasuda
et al., 2011; Tajiri et al., 2012). Consequently, this research paved
the way for translation of laboratory studies on stem cells into
limited clinical trials for brain disorders (Pollock et al., 2006;
Yasuhara et al., 2009; Seol et al., 2011). Despite these scientific
advances and clinical applications, the mechanisms underlying
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FIGURE 1 | Multiple mechanisms underlying stem cell therapy. (A) Cell
replacement entails that transplanted cells replace dead or dying host cells,
which would require neuronal differentiation of stem cells and reconstruction
of the damaged synaptic circuitry. (B) By-stander effects involve secretion of
neurotrophic factors, anti-inflammatory substances, and anti-oxidative stress
molecules by the transplanted cells, which subsequently rescue spared host
cells or stimulate neurogenesis. (C) Stem cell-paved biobridges show that
transplanted cells form a biological pathway, enriched in MMPs, and ferries
newly born host stem cells from the neurogenic niche SVZ to the injured host
tissue.
stem cell-mediated repair in brain injury are not yet completely
understood.
In a recent study, we demonstrated motor and neurologi-
cal improvements in rats subjected to traumatic brain injury
(TBI) and transplanted intracerebrally with cultured Notch-
induced human bonemarrow-derived mesenchymal stromal cells
(referred to as SB623, supplied by SanBio Inc.) While we obtained
important results that corroborate the putative therapeutic ben-
efits of stem cell transplantation for TBI, our research on the
mechanism of action of SB623 revealed breakthrough findings
which support the discovery of a novel stem-cell mediated repair
mechanism in brain injury. Accordingly, we observed the capac-
ity of transplanted stem cells to harness a “biobridge” between
the neurogenic niche and the site of brain injury, enabling long-
distance migration of host neurogenic cells and consequently,
initiating endogenous repair mechanisms. In this paper, we dis-
cuss the properties and characteristics of these stem cell paved-
biobridges, elaborate on the unique mechanism by which these
biobridges facilitate repair in a rat model of TBI, and importantly,
suggest the clinical significance of exploiting this novel stem cell-
mediated concept of brain repair for the treatment of brain injury
and other neurological disorders.
BREAKTHROUGH DISCOVERY: STEM CELL-PAVED
FORMATION OF “BIOBRIDGES” IN EXPERIMENTAL MODELS
OF TBI
Rats subjected to TBI were intracerebrally transplanted with
SB623 (gene-modified human mesenchymal stromal cells) (Zhao
et al., 2007; Yasuhara et al., 2009). Thereafter, the motor and
neurological functions of these rats were evaluated at 1, 2, and
3 months post-TBI, and histological studies were performed
to assess the therapeutic effects of SB623 transplantation. The
behavioral studies showed significant motor and neurological
improvement in TBI rats which received SB623. Histological stud-
ies also showed profound reduction in TBI-induced damages
to the cortical core and the peri-injured cortical areas in
SB623-transplanted TBI rats. The behavioral and histological
improvements, however, were achieved despite minimal graft
survival—0.60 and 0.16% at 1 and 3 months, respectively. These
findings led us to examine the condition of the host tissue, in view
of functional recovery despite lack of graft persistence.
At 1 month post-TBI, we observed notable increases in
endogenous cellular proliferation (Ki67) as well as immature neu-
ral differentiation (nestin) in the peri-injured cortical areas and
SVZ, along with a stream of migrating cells along the corpus cal-
losum (CC) of SB623 transplanted TBI animals. Furthermore,
at 3 months post-TBI, we observed enhanced cellular prolifera-
tion and neural differentiation in the peri-injured cortical (CTX)
areas of SB623 transplanted TBI animals, accompanied by a solid
stream of neuronally-labeled cells (nestin and DCX) migrating
not only along but also across the CC from the SVZ to the
impacted CTX. Contrastingly, TBI rats which received vehicle
infusion exhibited elevated cellular proliferation; however the
newly formed cells were “trapped” within the SVZ and CTX and
did not migrate to the impacted CTX.
We next analyzed the formation of the biobridge by means of
the cells leaving the SVZ and moving toward the site of injury was
laser captured in the animals receiving the SB623 cells.
The biobridge between the SVZ and the impacted cortex
was composed of highly proliferative, neutrally committed, and
migratory cells. These animals showed a 2 and 9-fold upreg-
ulation of the matrix metalloproteinase-9 (MMP) activity and
expression at 1 and 3 months post-TBI, respectively. Further
in vitro studies also showed the ability of SB623 cells to enhance
cell migration via this MMP-rich signaling cues. These signals are
crucial to the migration of endogenous cells which can then assist
with functional recovery of damaged tissue. Merely 1month post-
TBI, a surge of proliferative Ki67 positive cells and neurally imma-
ture nestin labeled cells in the peri-injured areas and SVZ were
discerned. The high level of MMP-9 in the biobridge indicates the
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importance of this neurovascular proteinase. Interestingly, this
proteinase was upregulated in the vehicle group, but reverted back
to control-sham levels at 3 months post-TBI. This illustrates the
role of MMP in long-term recovery and adds another facet to the
mechanism through which stem cells aid in recovery of damaged
tissue.
To provide further evidence that the implanted SB623 cells
facilitated the formation of the biobridge, thus enabling the
migration of host stem cells from the SVZ to the site of injury
and the up-regulation of endogenous cells, an in vitro study
was performed with primary rat cortical cells grown both alone
and co-cultured with SB623 cells. These were grown either in
the presence or absence of the MMP-9 inhibitor Cyclosporin-A.
Migratory cell assay revealed noticeably enhanced migration of
primary rat cortical cells in the chamber containing SB623, which
was then significantly suppressed by treatment with the MMP-9
inhibitor. Treatment with the inhibitor alone, combined treat-
ment with SB623 and the inhibitor, and absence of both SB623
and the inhibitor did not significantly alter migratory potential.
Although endogenous repair mechanisms are initiated post-
TBI, these effects are typically limited to the neurogenic SVZ
and quiescent neurogenic resident cells around the impacted cor-
tex. Accordingly, these endogenous mechanisms are not robust
enough to provide a solid defense against TBI or other disease-
induced cell death cascades necessitating introduction of exoge-
nous cells to aid migration of endogenous stem cells from the
neurogenic niche to the site of injury. Stem cell transplantation
into the peri-injured cortical areas purportedly creates a bio-
bridge comprised of a neurovascular matrix which allows newly
formed endogenous cells tomigrate efficiently to the site of injury.
Moreover, biobridge is established, exogenous cells slowly fade
away, supplanted by newly formed endogenous cells that can
maintain recovery even in the absence of transplanted stem cells.
A BIOBRIDGE BETWEEN THE NEUROGENIC NICHE AND THE
ISCHEMIC TISSUE
The results show SB623 transplants aid in regeneration of the
traumatically injured brain by constructing a biobridge between
the SVZ and the peri-injured cortex (Figure 1C). This novel
mechanism opens new doors for cell therapy by allowing the
creation of similar biobridges between neurogenic and non-
neurogenic sites to aid in injury-specific migration of cells across
tissues that are barriers to cellular motility.
A phase I/IIa study of SB623 cell transplantation in chronic
stroke patients has already been initiated. Transplantation of
SB623 cells has been shown to mitigate histological and behav-
ioral deficits associated with stroke, spinal cord injury, and
Parkinson’s Disease in both cell culture and animal models of
brain disorders. The use of SB623 cells in TBI patients is an inno-
vative concept that has already been FDA approved for a limited
clinical trial based on the data presented.
Understanding SB623’s role in facilitating the migration of
endogenous cells via a biobridge exposes the active role of MMPs
and ECMs in stroke pathology (Park et al., 2009; el Zoppo et al.,
2012) and highlights their increasingly prominent role as thera-
peutic targets for stroke. Functions and levels ofMMPs and ECMs
have been shown to be influenced by a variety of cells coming
from variable sources including umbilical cord blood, periph-
eral blood, and the adult brain (Barkho et al., 2008; Sobrino
et al., 2012; Lin et al., 2013). This suggests a potential for these
molecules to serve as biobridges similar to the current function of
Notch-induced SB623 mesenchymal stromal cells.
While documented neurogenic niches such as the SVZ exist in
the adult brain and contain cells that play a critical role in repair-
ing the stroke brain (Ekdahl et al., 2009; Ducruet et al., 2012;
Hassani et al., 2012; Wang et al., 2012; Trueman et al., 2013),
it has been shown that a major limiting factor for endogenous
repair is the lack of successful migration of newly formed host
cells to the site of injury. Currently, results show SB623 cell trans-
plantation boosts endogenous repair mechanisms by guiding the
transition of new cells from the neurogenic SVZ, across a non-
neurogenic brain area, to the site of injury. The ability of SB623
cells to form biobridges containing MMPs and ECMs which can
then entice newly formed cells from the niche into the ischemic
tissue appears to be a fundamental mechanism of action. Once the
transplanted SB623 cells have pioneered the formation of these
biobridges, they allow the endogenous stem cells to take over the
remodeling process.
The precise mechanism by which the graft cells are integrated
into the recipient brain tissue and subsequently interact with the
host cells to result in functional restoration remains unknown.
This essential interaction between the transplanted cell and host
cell becomes even more obscure when graft survival is minimal.
This indicates that the role of the SB623 is to set in motion robust
and stable therapeutic benefits, particularly by leading the way for
host cells to reach the injured site even across non-neurogenic and
injured tissues. MMP has been implicated in chronic brain injury
recovery through studies that inhibited MMPs, which conse-
quently halted neurogenic migration from the SVZ into damaged
tissues. The result was a noticeable retardation in neurovascular
remodeling. This supports the concept that exogenously added
cells can express MMPs and thereby reinforce the neurovascu-
lar unit, aiding in the transplant-mediated host cell migration
toward the site of injury. This potentially allows for the formation
of biobridges, thereby affording functional recovery in TBI.
BEYOND TBI: EXPLOITING STEM CELL-PAVED BIOBRIDGES
FOR THE TREATMENT OF OTHER NEUROLOGICAL
DISORDERS
The most adult stem cells in the brain are found in the SVZ of
the lateral ventricles and the subgranular zone of the hippocam-
pus dentate gyrus. The microenvironment of a stem cell niche is
maintained by the signaling molecules, growth factors, and recep-
tors. In adults, these stem cells typically remain in a dormant
non-dividing state until activated by an insult. When an insult
occurs motility ensues and the endogenous stem cells find them-
selves trapped and unable to reach the site of injury. The novel
discovery that grafted cells can facilitate endogenous stem cell
migration from the neurogenic niche to the site of injury is indeed
a significant progress in the both stem cell and TBI research.
Our recent study (Tajiri et al., 2013) advances the concept of
the biobridgemechanism as a cell mediated repair strategy in TBI,
and opens new avenues for translational applications of cell ther-
apy in TBI. Monitoring long term safety and efficacy of SB623
Frontiers in Systems Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 116 | 3
Tajiri et al. Bridging the gap in TBI
cell therapy in TBI animal models in order to optimize the con-
duct of clinical trials involving these cells in TBI patients is a
priority. Gaining a more concrete understanding of the stem cell
mechanism is the next step which will help to push forth the
boundaries of stem cell research and explain the mechanism of
cellular therapy in neurological disease.
In addition to TBI, a number of other neurological disor-
ders are characterized by a “biological gap” between the site of
injury and intact tissue. In this regard, disorders like stroke and
Parkinson’s disease may benefit from a deeper understanding on
the concept of stem cell-paved biobridge because both disor-
ders present with a site of cellular degeneration that is physically
separated from the area of the brain that could aid in the recov-
ery of dead tissue or lost cells. For example, stroke entails an
ischemic core and penumbra residing next to intact tissue. While
the ischemic core damage cannot be recovered, the potential for
neural repair has been demonstrated by targeting the penumbra.
Accordingly, a biobridge between the penumbra and the intact
tissue (i.e., neurogenic niche) could potentially aid in stroke.
Parkinson’s disease involves the degeneration of the nigrostri-
atal dopaminergic pathway, which could improve drastically with
directed migration of host stem cells toward this region in the
form of a biobridge. Further investigations are warranted to deter-
mine how the concept of stem-cell paved biobridge could be
exploited for the treatment of other neurological disorders.
MULTI-PRONGED MECHANISMS UNDERLYING STEM CELL
THERAPY
As noted above, stem cell-mediated repair mechanisms have been
widely purported as afforded via cell replacement and bystander
effects (Snyder et al., 1997; Borlongan et al., 2004; Lee et al.,
2007; Redmond et al., 2007; Pastori et al., 2008; Acosta et al.,
2014). Our proposed third mechanism describes the recruitment
of endogenous stem cells from the stem cell niches (Alvarez-
Buylla et al., 2008) to the injured site through the transplanted
stem cell-formed biobridge. This begs the question of whether the
biobridge provides the scaffold or trophic factors to promote stem
cell migration. Interestingly, new reports suggest candidate ECMs
may serve as a scaffold or trophic factor-rich soluble molecules.
For example, a study observed that the limits of interstitial cell
migration depends upon scaffold porosity and deformation of the
nucleus, with pericellular collagenolysis and mechanocoupling as
modulators acting as scaffolds and assisting with biobridge for-
mation (i.e., stem cell migration) (Wolf et al., 2013). Alternatively,
a study found that functional analysis of mesenchymal stem cell
proliferation, migration, and adhesion to ECMs revealed that IL-
1β did not affect proliferation but served to induce the secretion
of trophic factors and adhesion to ECM components such as
collagen and laminin (Carrero et al., 2012).
In the end, stem cell functionality is a key factor to achieve
clinically relevant outcomes of stem cell therapy. Of note, neuro-
genesis per se does not equate to these new neurons integrating
with the damaged area, and that physiological and functional
assays (e.g., synaptic circuitry reconstruction, evoked potentials,
long-term potentiation, etc.) will be necessary to unequivocally
reveal the contribution of these newly formed cells in the result-
ing behavioral recovery. Depending on the target disease of stem
cell therapy, it is likely that neuronal differentiation to spe-
cific disease-phenotype (Hong et al., 2011), as in the case of
Parkinson’s disease and Huntington’s disease, may be needed to
produce functional effects. However, we caution that such neu-
ronal differentiation may occur in both exogenously transplanted
cells and the mobilized endogenous stem cells. Our concept of
biobridge formation highlights the need for these stem cells to
be guided toward the site of injury, which may facilitate the ther-
apeutic effects of these newly formed cells that have committed
to neuronally differentiated cells. Alternatively or a complement
mechanism in the absence of neuronal differentiation, we also
propose the biobridge-facilitated by-stander effects, in that with
the directed migration of these stem cells toward the site of injury,
the biobridge is able to harness the secretion of growth fac-
tors, anti-inflammatory substances, and/or anti-oxidative stress
molecules close to the damaged area.
The concept of stem cell-paved biobridge may have some sim-
ilarities with the use of olfactory ensheathing glia in spinal cord
injury. Compelling evidence from animal models and clinical
studies suggest that transplantation of olfactory ensheathing cells
(OECs), specialized glia in the olfactory system, combined with
specific training may be therapeutically useful in central ner-
vous system (CNS) injuries and neurodegenerative diseases. The
unique function of OECs could be attributed to both produc-
tion of cell adhesion molecules and secretion of growth factors
in OECs, which support neuron survival and neurite outgrowth
(He et al., 2013). Another study showed that transplantation of
OEG and Schwann cell (SCs) in a sub-acute phase can improve
anatomical outcomes after a contusion injury to the spinal cord by
increasing the number of spared/regenerated supraspinal fibers,
reducing cavitation, and enhancing tissue integrity (Barbour
et al., 2013). Most spinal cord injury models evaluating the ther-
apeutic efficacy of OEC transplants have reported functional
recovery via indirect and direct reparative pathways involving
growth factor secretion, neuronal and axonal regeneration, and
remyelination (Roet et al., 2013).
Although similarities exist between the biobridge seen with
OECs in spinal cord injury and our observed biobridge in TBI,
the biobridge seen in spinal cord injury involves the ensheating
features of OECs, as well as the fabrication of scaffolds (such
as laminin and fibronectin) and seeding the stem cells onto
these matrices in order to create a biobridge. In contrast, our
observed biobridge involves a natural process of the stem cells
themselves serving as matrices in facilitating the migration of
endogenous stem cells from the neurogenic niche toward the
injured host tissue. With this in mind, a similar biobridge strategy
was documented in Parkinson’s disease whereby the transplanted
dopamine-secreting cells were deposited along the nigrostriatal
system (instead of merely transplanting the cells into the stria-
tum) to closely reconstruct the major dopaminergic afferent and
efferent pathways (Wang et al., 1996; Tang et al., 1998; Chiang
et al., 2001). Compared to our observed biobridge formation,
this bridging graft in Parkinson’s disease is an artificial recon-
struction of the dopaminergic system whereby micro-deposits
of immature cells are undertaken along the nigrostriatal path-
way, whereas our biobridge formation reveals a natural process
of the transplanted stem cells homing from the neurogenic niche
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and forming a bridge toward the injured site, and subsequently
attracting endogenous stem cells to populate the biobridge and to
eventually continue the brain reparative process.
Altogether, these observations suggest that while distinct
mechanisms of action may be individually facilitating the neural
repair of transplanted stem cells in the injured brain, overlap-
ping regenerative processes involving cell replacement, by-stander
effects, and biobridge formation may be working in tandem in
realizing the therapeutic benefits of stem cell therapy.
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